Prevalence of Aspiration Risk Assessed by Gastric Ultrasonography in Diabetic Patients Undergoing an Elective Surgery
- Conditions
- Diabetic patients with elective surgeryPrevalence, Diabetes mellitus, High risk pulmonary aspiration, Gastric ultrasound assessment
- Registration Number
- TCTR20230615004
- Lead Sponsor
- Faculty of Medicine, Srinakharinwirot University
- Brief Summary
The prevalence of the risk of aspiration of gastric content from the stomach into the lungs, characterized by retained gastric contents and a gastric volume greater than 1.5 mL/kg, in diabetic patients undergoing emergency surgery, was found to be 18.49% using ultrasound. Significant risk factors associated with this condition were age (65-84 years) and elevated BUN levels, with odd ratios of 20.81 (95%CI 2.01-215.54) and 1.05 (95%CI 1.01-1.09), respectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 119
patients aged 18 years or older, patients diagnosed with type 2 diabetes for at least 3 months, and patients undergoing non-emergency surgery following fasting guidelines
patients who cannot adhere to fasting standards or undergo emergency surgery, patients with COVID-19 or positive PUI, patients with type 1 diabetes, patients with diabetes accompanied by high blood sugar conditions such as diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome, patients with abnormal gastrointestinal motility, patients with acute gastrointestinal bleeding, patients with intestinal obstruction, patients with gastric ulcers, patients with liver abscess, patients with small and large intestinal tumors, or patients with a history of gastrointestinal surgery, except for liver cirrhosis, choledochal cysts, gastroesophageal reflux disease, peptic ulcers, and small intestine ulcers. Patients undergoing peritoneal dialysis (CAPD) and patients with other conditions specified in the data collection form that may cause bowel ileus, such as hypokalemia, hyponatremia, hypomagnesemia, and sepsis, are also excluded. Pregnant patients, patients with nasogastric or orogastric tubes, patients who have taken medications affecting gastric function and acid levels, such as prokinetic drugs, H2-blockers, tricyclic antidepressants, and glucagon-like peptide (GLP)-1 agonists within 2 hours before anesthesia induction, patients with mental health problems, or patients who are unable to provide information regarding fasting
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method